Table 2.
Characteristics of the ibuprofen film-coated tablets marketed in 2015
| Code | Sales (%) | Batch | Expiration date | Weighta (mg) | Hardnessb (N) | Disc (min) | Q5d (%) | MAe (years) | Other generics |
|---|---|---|---|---|---|---|---|---|---|
| A’ | 10.25 | 65899PC | 04/2019 | 787.3 (1.7) | 159.8 (141.4–183.7) | 6.6 | 34.9 (10.3) | ||
| B’ | 17.65 | 6,015 | 02/2019 | 960.7 (11.5) | 160.9 (146.8–176.3) | 3.3 | 57.1 (12.0) | 15 | 156 |
| C’ | 14.2 | IBPA1559 | 10/2018 | 822.3 (10.1) | 129.7 (91.0–155.8) | 3.4 | 56.8 (18.2) | 8 | 156 |
| K’ | 7.78 | 08,076 G1 | 10/2018 | 776.3 (3.1) | 132.6 (121.9–150.8) | 11.5 | 33.6 (23.6) | 11 | 60 |
| F’ | 7.36 | L0M × 1 | 02/2018 | 870.0 (5.9) | 199.1 (180.0–214.3) | 9.1 | 37.2 (18.2) | 12 | 190 |
| I’ | 6.18 | 1017813 | 05/2017 | 779.0 (2.7) | 155.2 (130.0–174.0) | 9.5 | 48.6 (20.0) | 2 | 135 |
| L” | 5.13 | FX8442 | 12/2017 | 774.1 (3.0) | 142.1 (134.3–149.8) | 12.1 | 28.0 (19.2) | 11 | 165 |
| D” | 4.39 | K007 | 11/2019 | 783.4 (5.8) | 165.2 (146.8–188.7) | 7.6 | 46.0 (17.7) | 10 | 191 |
| E’ | 4.34 | K0301 | 01/2019 | 980.2 (5.3) | 222.3 (185.4–250.2) | 11.3 | 9.2 (39.6) | 10 | 102 |
| H’ | 3.34 | 1019145 | 06/2017 | 785.0 (2.6) | 162.4 (150.8–185.1) | 10.5 | 35.0 (19.2) | 4 | 152 |
| J’ | 2.98 | K327 | 05/2018 | 1,110.4 (8.4) | 162.7 (151.1–172.0) | 7.2 | 51.8 (6.9) | 12 | 86 |
| G’ | 2.87 | 1017158 | 03/2020 | 774.4 (4.1) | 168.1 (154.8–176.3) | 15.0 | 30.4 (31.3) | 9 | 132 |
| M’ | 2.85 | 1020090 | 09/2017 | 774.7 (6.5) | 163.1 (150.8–181.0) | 7.0 | 42.2 (21.9) | 10 | 62 |
| N’ | 1.65 | 5JN037A | 09/2018 | 763.1 (9.5) | 110.0 (89.0–125.3) | 12.3 | 31.7 (12.3) | 5 | 45 |
Notes:
a
Values in parenthesis are SD.
b
Mean value (minimum and maximum forces).
c
Disintegration time.
d
Values in parenthesis are the coefficients of variation.
e
Marketing age; time in years after approval.